Besins Healthcare is a pharmaceutical company specialising in the development of innovative drugs for the well-being of men and women throughout their life.
Ian, aged 69
Patient profile is fictional and for illustrative purposes only.
Consider screening for testosterone deficiency (TD) in men with a history of anaemia.1
The Endocrine Society’s Clinical Practice Guidelines recommend measuring testosterone and offering testosterone replacement therapy on an individualised basis for men aged >65 with symptoms or conditions suggestive of TD (including unexplained anaemia), after discussions of the potential risks and benefits.2
Patients with unexplained anaemia can be screened easily for symptoms of TD using the Androgen Deficiency in Ageing Males (ADAM) questionnaire and/or Ageing Males’ Symptoms (AMS) scale. These tools are simple, effective and can be quickly filled out during a patient appointment, to help you catch symptoms of TD that may not be proactively mentioned by men during follow-up appointments.3
If symptoms are present, completing a simple blood test to determine if a patient has low serum testosterone levels can confirm a diagnosis of TD.2,4
TES/2020/009. April 2021.
Adverse event reporting
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Besins Healthcare (UK) Ltd Drug Safety on 0203 862 0920 or Email: email@example.com
TD could be causing anaemia in your male patients. Learn about the link between TD and unexplained anaemia.